VANQUA BIO

Founded in 2019, Vanqua Bio is a biopharmaceutical company focused on discovering and developing next-generation medicines for neurodegenerative diseases. Our novel drug-development approach combines advanced insights into critical neuronal cell pathways with cutting-edge assays to advance needed therapies. Our lead program targets glucocerebrosidase (GCase) as a potential treatment for Parkinson's disease (PD) and Dementia with Lewy Bodies (DLB). Additional programs address overactivation of the innate immune system in central and peripheral disorders, including Alzheimer's disease... Vanqua Bio is helping usher in a new era of hope for patients living with neurodegenerative disorders. Toward that end, we have assembled a world-class team of scientists, board members, and advisors with proven capabilities in advancing molecules that become transformative medicines... Combining the key ingredients of scientific expertise, creativity, and experience, our team embraces the challenge..

Primary location: Chicago United States